Does angioedema caused by lisinopril (angiotensin-converting enzyme inhibitor) typically present with a rash?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Angioedema from Lisinopril Cause a Rash?

No, angioedema from lisinopril does not typically cause a rash. ACE inhibitor-induced angioedema characteristically presents as asymmetric, non-pitting swelling that is not pruritic and occurs without urticaria (hives) 1.

Key Clinical Features of ACE Inhibitor-Induced Angioedema

ACE inhibitor-associated angioedema is specifically characterized by swelling without accompanying skin manifestations:

  • The swelling is asymmetric, non-dependent, and generally not pruritic 1
  • Treatment with ACE inhibitors has been associated with recurrent angioedema without urticaria, prominently involving the face and tongue but also other areas including rarely the bowel and extremities 1
  • The mechanism is bradykinin-mediated (not histamine-mediated), which explains the absence of urticaria 1

Critical Diagnostic Distinction

The absence of urticaria/rash is a key diagnostic feature that distinguishes ACE inhibitor angioedema from other types:

  • Most cases of recurrent angioedema that occur with concomitant urticaria or pruritus are histamine-mediated and are best considered within the spectrum of chronic urticaria—these are NOT ACE inhibitor-induced 1
  • If a patient presents with both angioedema and urticaria/rash while on an ACE inhibitor, this suggests an alternative diagnosis such as allergic or histamine-mediated angioedema rather than the typical ACE inhibitor class effect 1

Clinical Presentation Details

When evaluating suspected ACE inhibitor angioedema, look for:

  • Swelling of face, lips, tongue, glottis, and/or larynx 2
  • Swelling of extremities 1
  • Rarely, intestinal angioedema presenting with abdominal pain (with or without nausea/vomiting) 2
  • Absence of skin rash, hives, or pruritus 1
  • Symptoms can occur within the first month of therapy but may develop even after many years of continuous use 1

Common Clinical Pitfall

Do not confuse ACE inhibitor angioedema with allergic reactions:

  • If urticaria/rash is present, consider IgE-mediated hypersensitivity or other causes of histamine-mediated angioedema 1
  • ACE inhibitor angioedema does not reliably respond to epinephrine, antihistamines, or corticosteroids because it is bradykinin-mediated, not histamine-mediated 1
  • The definitive management is immediate discontinuation of the ACE inhibitor 1, 2

Life-Threatening Considerations

Recognize that ACE inhibitor angioedema can be fatal even without rash:

  • There are published reports of deaths from ACE inhibitor-induced laryngeal edema leading to complete upper airway obstruction 1
  • Patients with involvement of the tongue, glottis, or larynx are likely to experience airway obstruction 2
  • The swelling tendency can continue for at least 6 weeks after discontinuation of the ACE inhibitor 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.